Accrued Expenses

3 Months Ended

Mar. 31, 2022

Accrued Expenses

Accrued Expenses

Note 4. Accrued Expenses

The following is a summary of the Company’s accrued expenses:

	March 31,		December 31,
	2022		2021
Clinical trial expenses	$	1,997,721	$	2,625,779
Other		594,575		330,766
Total	$	2,592,296	$	2,956,545